You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 22, 2018

Clearing the Air on Cannabis Patents

Bangkok Post

The patent system has become an unlikely hot topic in Thailand in light of reports that some overseas pharmaceutical companies have applied for Thai patents for cannabis. The revelations have added more fuel to the ongoing debate about the utility of cannabis, a Thai local plant. The reports have led many to criticize the patent system, questioning whether patent rights may obstruct Thai researchers’ studies on cannabis. It is important not to oversimplify this issue. Such dialogue is extremely important and must be encouraged, but as a patent attorney I find the broader context of the patent system very enlightening in understanding the arguments on both sides.

The most important context of course is the reasoning behind the patent system in the first place. An internationally accepted rationale for patent law is that a patent grants security to an inventor who, through his or her intellect and labor, has conceived an invention that benefits the society. Granting that inventor patent rights prevents others from exploiting the fruit of that inventor’s labor without consent. Simply put, patents prevent anyone from stealing an inventor’s idea. In exchange, the inventor has a duty to make the details (or the “secret trick”) of his or her invention available to the public through the process of patent application. Importantly, a patent is in force for no more than 20 years, after which the knowledge in that patent will become public information for anyone’s free use.

With that in mind, we can begin to look at the specific context of cannabis-based patents.

 

The patent system has become an unlikely hot topic in Thailand in light of reports that some overseas pharmaceutical companies have applied for Thai patents for cannabis. The revelations have added more fuel to the ongoing debate about the utility of cannabis, a Thai local plant. The reports have led many to criticize the patent system, questioning whether patent rights may obstruct Thai researchers’ studies on cannabis. It is important not to oversimplify this issue. Such dialogue is extremely important and must be encouraged, but as a patent attorney I find the broader context of the patent system very enlightening in understanding the arguments on both sides.

The most important context of course is the reasoning behind the patent system in the first place. An internationally accepted rationale for patent law is that a patent grants security to an inventor who, through his or her intellect and labor, has conceived an invention that benefits the society. Granting that inventor patent rights prevents others from exploiting the fruit of that inventor’s labor without consent. Simply put, patents prevent anyone from stealing an inventor’s idea. In exchange, the inventor has a duty to make the details (or the “secret trick”) of his or her invention available to the public through the process of patent application. Importantly, a patent is in force for no more than 20 years, after which the knowledge in that patent will become public information for anyone’s free use.

With that in mind, we can begin to look at the specific context of cannabis-based patents.

Current State of Cannabis Patents in Thailand

A preliminary investigation into the Department of Intellectual Property (DIP) database shows that 91 patent applications have been filed in Thailand relating to the group of chemicals found in cannabis. This search excludes any incidental uses such as traditional medicines and textile industry applications. Among these, only one application has been registered as a Thai patent, and that patent was later revoked. Of the remaining 90 applications, 51 were abandoned without registration. The remaining 39 have been published and are pending substantial examination by the DIP.

It is important to clarify that a patent application is not the same as patent registration. Rights do not exist until an application is registered, and before registration the applicant has no right to sue anyone. Therefore, no one, Thai or foreign, is currently able to sue anyone for infringing a cannabis extract patent in Thailand.

Natural Substances

One hotly debated point is whether or not people should be able to patent “natural substances.” This is an odd argument from a patent attorney’s point of view, because the law already addresses it. Section 9 (1) of the Thai Patent Act B.E. 2522 (1979) expressly prevents “animals, plants or extracts from animals or plants” from being patented. The next logical step is to dig deeper into what that actually means.

The DIP’s Patent Examination Guideline B.E. 2555 (2012), section 1, part 1, page 28, explains that unpatentable “animals, plants or extracts from animals or plants” includes “higher animals and higher plants that are available in nature” and “extracts from animals or plants that have not undergone any man-made substantial processing” (emphasis added). The underlying reason is that a protectable invention must owe its existence to human’s intelligence. The existence of plants, animals, or other things that exist in nature may not be claimed by a human. In cannabis’ case, this law means that the cannabis plant, including its stem, flower, leaf, and crude extracts are not patentable. 

On the other hand, if a human brings a natural thing to be processed by technical means, and thereby causes results and benefits that are not found in the natural state of that thing, then that processed natural thing may be patented. For example, suppose that a certain plant contains Substance A which, in its natural state, does not exhibit any therapeutic effects. Suppose that a researcher later found a way to transform Substance A, or make a pharmaceutical formula containing Substance A, which enables Substance A to perform as an active ingredient for effective treatment of hypertension. The method for transforming that substance, or the pharmaceutical formula, is an invention which may be lawfully patented.

Section 9 (1) must be interpreted with care, and in the proper context of the rationale for patent law, to avoid it leading to slippery slope arguments that negatively affect the patent system. It is true that all human inventions can be traced back to products of nature. For example, many polymers are derived from crude oil, which is found in nature. However, a new petroleum-based polymer that is stronger than steel should be patentable, despite being developed from a product of nature. If Section 9 (1) is interpreted to mean that anything related to nature in any way cannot be patented, then nothing would be patentable.

Preventing the Obstruction of Research

Another hotly debated issue surrounding cannabis patents is a concern that Thai patent registration (which has yet to occur, as noted above) may obstruct medical cannabis research by Thai researchers. This is a rather unlikely scenario for two extremely important reasons.

Firstly, patent protection has a limited scope. Using the Substance A example above, suppose that a patent has been issued for the use of Substance A as a treatment for hypertension (and that the patent has passed all other provisions of the Patent Act). That patent will only cover the use of Substance A for the reasons, and by the means, specified in the patent. The patentee has no right to prevent others from using Substance A for other purposes, for treating other illnesses, or for treating hypertension by a means that is substantially different from what is specified in the patent. In addition, since the patent claims for the “use,” not for Substance A itself (which cannot be patented, as noted above), the patentee is not entitled to prevent others from using or handling Substance A in any other way.

Secondly, research and study are not patent infringement. Section 36, paragraph 2, subsection 1 of the Patent Act provides that “any act for the purpose of study, research, experimentation or analysis” does not infringe upon any patent. This means any study or research that does not compete with the patentee’s business, such as a research conducted by a professor in a medical school, will not expose the researcher to any liability.

The Usefulness of Patents

Finally, in considering these matters in the broader context, it is important to be aware of the general usefulness of the patent system in a broader sense. The patenting system is important for the modern economy. It incentivizes research and development activities, and it allows for knowledge transfer for the public benefit. Patent applications must disclose clear and detailed information about the invention that they relate to, making the complete details of an invention publicly available, from which new ideas and further developments will arise. Researchers are free to study the patents and then seek a technical improvement, which may be patentable in its own right. In addition, when the patent has expired (no longer than 20 years), the once-patented invention will become public knowledge available for anyone’s free use.

The case of cannabis patents is a great opportunity for the Thai public to converse, debate, and consider the benefits and shortcomings of the current patent law system, and hopefully to provide critiques for the betterment of our patent law. However, it is important for any such critique to have a good understanding of the facts on both sides of the argument, before a thorough analysis can take place.

RELATED INSIGHTS​ 

June 10, 2026
For multinational franchisors operating in Thailand, a key risk after franchise termination is that former outlets may continue operating in ways that could easily mislead consumers into believing they remain within the authorized network. To justify such operations, former franchisees often argue that the termination was invalid or ineffective. As a result, these cases are often treated as contractual disputes, making it difficult for franchisors to obtain injunctive relief before a final judgment confirms that the termination was lawful. Franchisors face significant commercial and reputational harm during lengthy proceedings, including consumer confusion, disruption to franchise restructuring, and damage to brand reputation and customer trust. In an encouraging development, the Thai court in a 2025 case responded to the problem of unauthorized post-termination franchise operations by granting interim relief, recognizing broader brand and consumer harm, and awarding substantial damages, highlighting a successful litigation strategy of framing the dispute not merely as a contractual termination issue but as trademark infringement causing ongoing commercial injury. The Subway Case From December 2024 to mid-2025, an unauthorized “Subway®” franchise operation in Thailand attracted substantial public and media attention. Reports and online discussions about unauthorized Subway® stores circulated widely after complaints arose about food quality and customer experience at certain outlets that were allegedly operating after their franchise rights had expired. Because these stores continued to use Subway® trademarks, trade dress, and overall commercial appearance, many consumers were unable to distinguish them from authorized operations, resulting in reputational risks and customer confusion that affected the franchisor’s brand and franchise system in Thailand. Subway treated this matter with the utmost seriousness and moved promptly to protect its brand, franchise system, and customers. It filed a civil action with the IP&IT Court seeking a permanent injunction and damages. During the proceedings, the court granted a preliminary injunction
May 22, 2026
Intellectual property specialists from Tilleke & Gibbins in Vietnam have contributed an updated Intellectual Property Transactions in Vietnam overview for Thomson Reuters Practical Law, an online publication that provides comprehensive legal guides for jurisdictions worldwide. The Vietnam overview was authored by Linh Thi Mai Nguyen, Thanh Phuong Vu, Chi Lan Dang, Son Thai Hoang, and Duc Anh Tran. The chapter provides a high-level examination of key aspects of IP transactions law in Vietnam, including IP assignment and licensing, research and development collaborations, IP in mergers and acquisitions (M&A), lending and taking security over intellectual property rights, settlement agreements, employee- and consultant-created IP, competition law, taxation, and non-tariff trade barriers. Key topics covered in the chapter include: IP assignment: Basis and formalities for assignments of patents, utility models, trade marks, copyright, design rights, trade secrets, confidential information, and domain names in Vietnam. IP licensing: Scope, formalities, and recordal requirements for licensing patents, trade marks, copyright, design rights, and trade secrets. Research and development collaborations: Treatment of improvements, derivatives, and joint ownership of IP, including exploitation and enforcement issues. IP aspects of M&A and security: Due diligence, warranties, transfer formalities, and taking security over intellectual property rights. Practical Law, a legal reference resource from Thomson Reuters, publishes a range of guides for hundreds of jurisdictions and practice areas. The Intellectual Property Transactions Global Guide is a valuable resource for legal practitioners seeking comparative insight into transactional IP issues across multiple jurisdictions. To view the latest version of the Intellectual Property Transactions in Vietnam overview, please visit the Practical Law website and enroll in the free Practical Law trial to gain full access.
May 13, 2026
Laos has significantly broadened its industrial property administrative review framework, most notably by extending it to cover copyright and related rights for the first time. Decision No. 0306/IC on the Administrative Resolution of Disputes Concerning Industrial Property Registration, New Plant Variety Registration, and Copyright and Related Rights Recordation took effect on April 24, 2026, replacing the previous rules from 2023, which had covered only industrial property and new plant variety matters. Decision No. 0306/IC governs how Laos’ Department of Intellectual Property (DIP) and provincial offices handle formal challenges to industrial property registrations and applications. The proceedings covered include oppositions to pending applications, appeals of refused applications, requests for cancellation of existing registrations, and—newly—disputes concerning the recordation and interpretation of copyright and related rights. These administrative proceedings within the DIP are heard by a government-appointed Administrative Dispute Resolution Committee, which functions similarly to the opposition and review boards found in other jurisdictions. Key Changes Decision No. 0306/IC covers four categories of administrative proceedings: Oppositions: Third-party challenges to a pending industrial property application before it is granted. Refusal appeals: Challenges to the DIP’s decision to refuse their application. Cancellation or deletion requests: Applications to invalidate an existing registered right on the grounds that it should not have been granted. Copyright and related rights disputes: Challenges to or interpretations of copyright and related rights recordations, including determinations of whether a work qualifies for copyright protection under Lao law. The most significant development is the committee’s new jurisdiction over copyright matters. The committee is now empowered to resolve disputes concerning copyright and related rights recordation—this includes the authority to determine whether a work qualifies for copyright protection and to interpret the scope of an existing recordation. Parties who believe a competitor has improperly recorded copyright over a work, or who wish to contest
April 30, 2026
Vietnam’s Decree No. 134/2026/ND‑CP, which took effect on 9 April 2026, plays an important role in detailing and implementing Vietnam’s Intellectual Property (IP) Law in the context of rapid digital transformation and the growing application of artificial intelligence (AI). The new decree provides comprehensive guidance on the application of copyright and related‑rights regulations, addressing key issues such as authorship, ownership, statutory exceptions and limitations, registration procedures, and enforcement mechanisms. Through these measures, Decree 134 seeks to achieve an appropriate balance between safeguarding the legitimate interests of rightsholders and fostering innovation, research, and technological advancement, thereby strengthening the state’s framework for the effective management, protection, and exploitation of intellectual property in the digital and AI‑driven environment. Some notable aspects of Decree 134 are discussed below. Copyright for AI-Created Works Decree 134 provides important guidance on the determination of copyright and related rights in works created with the assistance of AI. Article 5a reaffirms the principle that human creativity remains central to copyright protection, clarifying that copyright or related rights arise only where a human makes a substantial and decisive intellectual contribution, exercises effective control over the creative outcome, and assumes responsibility for the content and its legality. At the same time, the provision confirms that AI is regarded solely as a technological tool rather than a rights‑holding subject, thus ensuring consistency with the fundamental concepts of authorship and ownership under the IP Law. By introducing requirements on transparency, proof of human contribution, and compliance with AI‑specific labelling and technical marking obligations, Decree 134 establishes a clear and enforceable legal framework for the responsible use of AI in creative activities. Lawful Use of Copyrighted Texts and Data Article 37a of Decree 134 sets out the specific conditions under which copyrighted texts and data may be lawfully used for scientific research, experimentation,